2025-05-23 - Analysis Report
Okay, here's the analysis of Colgate-Palmolive Co (CL) based on the provided data, presented in an easy-to-understand format with clear headings and analysis.

**Report on Colgate-Palmolive Co (CL)**

**1. Performance vs. S&P 500 (VOO)**

*   **Ticker:** CL
*   **Company:** Colgate-Palmolive Co. (A global consumer products company focusing on oral care, personal care, home care, and pet nutrition.)

**Key Numbers:**

*   **CL Cumulative Return:** 23.29%
*   **VOO (S&P 500) Cumulative Return:** 80.67%
*   **Absolute Difference:** -57.38%
*   **Relative Difference (vs. min/max range):** 10.2%

**Analysis:**

Colgate-Palmolive (CL) has significantly underperformed the S&P 500 (VOO) over the period examined. The absolute difference in cumulative returns is -57.38%. The "Relative Difference" of 10.2% indicates that CL's underperformance is near the bottom end of its historical range relative to VOO.

**Alpha, Beta Analysis:**

| Year       | CAGR   | MDD   | Alpha   | Beta   | Cap(B) |
| ---------- | ------ | ----- | ------- | ------ | ------ |
| 2015-2017  | 13.0%  | 4.8%  | -16.0%  | 0.1    | 51.2   |
| 2016-2018  | -11.0% | 65.2% | -29.0%  | 0.1    | 41.4   |
| 2017-2019  | 7.0%   | 65.2% | -22.0%  | 0.2    | 49.1   |
| 2018-2020  | 18.0%  | 65.2% | -8.0%   | 0.7    | 62.4   |
| 2019-2021  | 30.0%  | 58.6% | -25.0%  | 1.0    | 63.7   |
| 2020-2022  | 8.0%   | 69.0% | 1.0%    | 1.0    | 60.2   |
| 2021-2023  | 8.0%   | 69.0% | -9.0%   | 0.9    | 62.5   |
| 2022-2024  | 15.0%  | 69.0% | -2.0%   | 0.8    | 72.8   |
| 2023-2025  | 10.0%  | 62.4% | -19.0%  | 0.3    | 73.7   |

**Analysis:**

*   **CAGR:** Varies significantly across different periods.
*   **MDD:** High Maximum Drawdown values suggest significant volatility.
*   **Alpha:** Predominantly negative, indicating underperformance relative to a risk-free asset or benchmark.
*   **Beta:** Generally low (mostly below 1), suggesting lower volatility than the market.
*   **Capital(B):** Market capitalization generally increased.

**2. Recent Price Action**

*   **Current Price:** $90.90
*   **Previous Close:** $91.67
*   **Change:** -$0.84
*   **5-day Moving Average:** 91.51
*   **20-day Moving Average:** 90.78
*   **60-day Moving Average:** 91.59

**Analysis:**

The stock price is slightly down from the previous close. The 5-day moving average is above the 20-day moving average, suggesting a short-term upward trend, but both are below the 60-day moving average, indicating a potential longer-term downward or consolidating trend.

**3. Technical Indicators & Expected Return**

*   **Market Risk Indicator (MRI):** 0.366 (Low Risk)
*   **RSI:** 52.22 (Neutral)
*   **PPO:** 0.1922
*   **20-day Relative Difference Change:** 1.8 (Short-term Increase)
*   **Expected Return:** -329.7% (Significant Underperformance vs. S&P 500)

**Analysis:**

*   **MRI:** Indicates a "Low Risk" environment, which is a positive sign.
*   **RSI:**  At 52.22, the RSI is neutral, not indicating overbought or oversold conditions.
*   **PPO:** Positive PPO indicate that short term moving average is trading above the long term moving average and the trend might be upward.
*   **20-day Relative Difference Change:** The recent increase suggests a short-term relative improvement compared to the S&P 500, although it's still significantly lagging.
*   **Expected Return:** The extremely negative expected return suggests that, based on the model,  long-term investment is projected to significantly underperform the S&P 500.
*   **Change:** The recent price change indicates a slight dip.

**4. Recent News & Significant Events**

*   **2025-05-21:** Major business developments, regulatory changes, or market events.
*   **2025-05-22:** Analyst discussions on recent performance and outlook.
*   **2025-05-23:** Stock volatility influenced by recent news, earnings, or executive actions.
*   **2025-05-19:** Market experts highlight risks and opportunities.

**Analysis:**

Recent news suggests that Colgate-Palmolive is experiencing volatility and is subject to market discussions regarding its performance and future outlook. Investors should pay close attention to company announcements, earnings reports, and analyst opinions.

**5. Recent Earnings Analysis**

| 날짜       | EPS  | 매출       |
| ---------- | ---- | ---------- |
| 2025-04-25 | 0.85 | 4.91 B$    |
| 2024-10-25 | 0.9  | 5.03 B$    |
| 2024-07-26 | 0.89 | 5.06 B$    |
| 2024-04-26 | 0.83 | 5.07 B$    |
| 2025-04-25 | 0.83 | 5.07 B$    |

**Analysis:**

*   **Revenue:** Revenue has been relatively stable, hovering around $5 billion. The most recent data shows a slight decrease.
*   **EPS:** EPS has fluctuated slightly, with the latest EPS (0.85) showing a slight decrease compared to previous periods.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
| ------------ | --------- | ------------- |
| 2025-03-31   | $4.91B    | 60.82%        |
| 2024-12-31   | $4.95B    | 60.30%        |
| 2024-09-30   | $5.03B    | 61.08%        |
| 2024-06-30   | $5.06B    | 60.62%        |
| 2024-03-31   | $5.07B    | 60.00%        |

**Capital and Profitability:**

| Quarter      | Equity    | ROE         |
| ------------ | --------- | ----------- |
| 2025-03-31   | $0.36B    | 190.08%     |
| 2024-12-31   | $0.21B    | 348.58%     |
| 2024-09-30   | $0.43B    | 169.43%     |
| 2024-06-30   | $0.12B    | 594.31%     |
| 2024-03-31   | $0.23B    | 296.96%     |

**Analysis:**

*   **Revenue:** Similar to the earnings analysis, revenue is relatively consistent.
*   **Profit Margin:** The profit margin is strong and stable, consistently above 60%.
*   **Equity:** Equity has fluctuated.
*   **ROE:** Return on Equity (ROE) is exceptionally high, indicating strong profitability relative to shareholder equity. However, the fluctuation in equity makes this metric volatile and warrants further investigation.

**7. Overall Summary**

Colgate-Palmolive (CL) is a stable consumer staples company with consistent revenue and high profit margins. However, it has significantly underperformed the S&P 500. The company's recent performance is being scrutinized by analysts, and the stock is experiencing some volatility. While the company shows strong ROE, the fluctuating equity suggests possible financial instability. The technical indicators present a mixed picture, with a neutral RSI and a low-risk MRI, but a negative expected return. The moving averages suggest a possible downward or consolidating trend.
